547 related articles for article (PubMed ID: 30386337)
1. Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression.
Gianchecchi E; Fierabracci A
Front Immunol; 2018; 9():2374. PubMed ID: 30386337
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
Kumar P; Bhattacharya P; Prabhakar BS
J Autoimmun; 2018 Dec; 95():77-99. PubMed ID: 30174217
[TBL] [Abstract][Full Text] [Related]
3. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
[TBL] [Abstract][Full Text] [Related]
4. Human Endothelial Cells Modulate CD4
Lim WC; Olding M; Healy E; Millar TM
Front Immunol; 2018; 9():565. PubMed ID: 29628925
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
6. The PD-1 pathway in tolerance and autoimmunity.
Francisco LM; Sage PT; Sharpe AH
Immunol Rev; 2010 Jul; 236():219-42. PubMed ID: 20636820
[TBL] [Abstract][Full Text] [Related]
7. Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage.
Li G; Lu C; Gao J; Wang X; Wu H; Lee C; Xing B; Zhang Q
Int J Clin Exp Pathol; 2015; 8(6):6512-8. PubMed ID: 26261529
[TBL] [Abstract][Full Text] [Related]
8. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
9. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
[TBL] [Abstract][Full Text] [Related]
10. Anti-regulatory T cells.
Andersen MH
Semin Immunopathol; 2017 Apr; 39(3):317-326. PubMed ID: 27677755
[TBL] [Abstract][Full Text] [Related]
11. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection.
Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G
Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043
[TBL] [Abstract][Full Text] [Related]
12. PD-1 is not required for natural or peripherally induced regulatory T cells: Severe autoimmunity despite normal production of regulatory T cells.
Ellestad KK; Thangavelu G; Ewen CL; Boon L; Anderson CC
Eur J Immunol; 2014 Dec; 44(12):3560-72. PubMed ID: 25236923
[TBL] [Abstract][Full Text] [Related]
13. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
14. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
Toor SM; Syed Khaja AS; Alkurd I; Elkord E
Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific Helios
Gotot J; Dhana E; Yagita H; Kaiser R; Ludwig-Portugall I; Kurts C
Immunol Cell Biol; 2018 Sep; 96(8):852-862. PubMed ID: 29617057
[TBL] [Abstract][Full Text] [Related]
16. Expression of PD-L1 on CD4+CD25+Foxp3+ Regulatory T Cells of Patients with Chronic HBV Infection and Its Correlation with Clinical Parameters.
Feng C; Cao LJ; Song HF; Xu P; Chen H; Xu JC; Zhu XY; Zhang XG; Wang XF
Viral Immunol; 2015 Oct; 28(8):418-24. PubMed ID: 26266813
[TBL] [Abstract][Full Text] [Related]
17. Programmed death-1 pathway in cancer and autoimmunity.
Pedoeem A; Azoulay-Alfaguter I; Strazza M; Silverman GJ; Mor A
Clin Immunol; 2014 Jul; 153(1):145-52. PubMed ID: 24780173
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis.
Concepcion AR; Salas JT; Sáez E; Sarvide S; Ferrer A; Portu A; Uriarte I; Hervás-Stubbs S; Oude Elferink RP; Prieto J; Medina JF
Oncotarget; 2015 Oct; 6(30):28588-606. PubMed ID: 26396175
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
[TBL] [Abstract][Full Text] [Related]
20. T Lymphocytes and Autoimmunity.
Khan U; Ghazanfar H
Int Rev Cell Mol Biol; 2018; 341():125-168. PubMed ID: 30262031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
